Headache or fatigue Mild headache or tiredness has been reported by some patients, typically easing as the body adjusts
Second-generation TKIs Dasatinib, nilotinib, ponatinib, and bosutinib are second-generation TKIs that are used for treatment of Ph+CML
The C-terminal domain of PLIN5 interacts with mitochondrial FATP4
While GLP-1 medications are effective for many people, they are not suitable for everyone
AAV-based in vivo gene therapy for neurological disorders
A long-acting release formulation, exenatide-LAR, delivers the drug in microspheres of a biodegradable polymer resulting in a prolonged half-life and allowing once-weekly administration, is also approved [4]